Jaagsiekte sheep retrovirus (JSRV) and enzootic nasal tumor virus (ENTV) are two closely related oncogenic retroviruses that share the same cellular receptor yet exhibit distinct fusogenicity and infectivity. Here, we find that the low fusogenicity of ENTV envelope protein (Env) is not because of receptor binding, but lies in its intrinsic insensitivity to receptor-mediated triggering for fusion at low pH. Distinct from JSRV, shedding of ENTV surface (SU) subunit into culture medium was not enhanced by a soluble form of receptor, Hyal2 (sHyal2), and sHyal2 was unable to effectively inactivate the ENTV pseudovirions. Remarkably, replacing either of the two amino acid residues, N191 or S195, located in the ENTV SU with the corresponding JSRV residues, H191 or G195, markedly increased the Env-mediated membrane fusion activity and infection. Reciprocal amino acid substitutions also partly switched the sensitivities of ENTV and JSRV pseudovirions to sHyal2-mediated SU shedding and inactivation. While N191 is responsible for an extra N-linked glycosylation of ENTV SU relative to that of JSRV, S195 possibly forms a hydrogen bond with a surrounding amino acid residue. Molecular modeling of the pre-fusion structure of JSRV Env predicts that the segment of SU that contains H191 to G195 contacts the fusion peptide and suggests that the H191N and G195S changes seen in ENTV may stabilize its pre-fusion structure against receptor priming and therefore modulate fusion activation by Hyal2. In summary, our study reveals critical determinants in the SU subunits of JSRV and ENTV Env proteins that likely regulate their local structures and thereby differential receptor-mediated fusion activation at low pH, and these findings explain, at least in part, their distinct viral infectivity.
Introduction
Enveloped viruses encode surface glycoproteins that recognize cellular receptors and mediate viral fusion and entry into the host cells (Cosset and Lavillette, 2011) . For many class I fusion proteins such as retrovirus envelope (Env), receptor binding and membrane fusion are executed by two associated subunits that are generated from proteolytic cleavage of a precursor by host proteases (White et al., 2008) . The retrovirus Env glycoproteins consist of a surface (SU) and a transmembrane (TM) subunit; SU is responsible for receptor binding, and TM mediates viruscell membrane fusion (Coffin et al., 1997) . At the prefusion state, the SU subunit acts as a clamp to restrict refolding of TM and thereby prevents premature fusion activation (Colman and Lawrence, 2003; Eckert and Kim, 2001) . Upon receptor binding, a conformational change occurs in the SU subunit that results in the disruption of the disulfide bond or non-covalent interactions between SU and TM; this causes the constraints of SU on TM to be released, leading to the formation of a six-helix bundle (6HB) in TM and therefore membrane fusion (Eckert and Kim, 2001; Li et al., 2008; Melikyan, 2008; Pinter et al., 1997; Wallin et al., 2004 Wallin et al., , 2006 . There is also strong evidence that the retroviral SU not only prevents the refolding of TM but can also send an indispensible signal to the TM subunit, since deletion of the receptor-binding domain (RBD) of SU results in fusion-deficient Env proteins, and soluble SU proteins containing RBD are sufficient to rescue their fusogenicities in trans (Barnett and Cunningham, 2001; Lavillette et al., 2001) .
While retroviruses are traditionally believed to fuse with host cells at the plasma membrane (McClure et al., 1990) , several retroviruses have been found to require a low pH for fusion and cell entry. These include ecotropic murine leukemia virus (E-MLV) (McClure et al., 1990; Nussbaum et al., 1993) , avian sarcoma and leukosis virus (ASLV) subgroups A and B (Diaz-Griffero et al., 2002; Mothes et al., 2000) , mouse mammary tumor virus (MMTV) (Redmond et al., 1984; Ross et al., 2002) , equine infectious anemia virus (EIAV) (Brindley and Maury, 2005; Jin et al., 2005) , foamy virus (Picard-Maureau et al., 2003) , as well as the oncogenic sheep retroviruses, jaagsiekte sheep retrovirus (JSRV) and enzootic nasal tumor virus (ENTV) that we recently reported (Bertrand et al., 2008; Côté et al., 2008a Côté et al., , 2008b . Among these, the ecotropic Moloney MLV (MoMLV) appears to require low pH-dependent cellular proteases for fusion activation (Kumar et al., 2007) , a novel mechanism that has been recently shown to be used by several other viruses for entry (Brindley et al., 2007; Chandran et al., 2005; Huang et al., 2006; Pager and Dutch, 2005; Pager et al., 2006; Schornberg et al., 2006; Simmons et al., 2005) . Notably, ASLV (Mothes et al., 2000) , JSRV (Côté et al., 2009) , and likely MMTV as well (Wang et al., 2008) , utilize an unusual two-step mechanism, where both receptor binding and low pH are required for fusion and cell entry.
JSRV and ENTV are simple betaretroviruses that induce contagious pulmonary and nasal adenocarcinoma in sheep and goats (Fan, 2003) . The Env proteins of JSRV and ENTV are active oncogenes that elicit cell transformation in vitro and induce tumor formation in animals (Allen et al., 2002; Caporale et al., 2006; Liu and Miller, 2007; Maeda et al., 2001; Rai et al., 2001; Wootton et al., 2005 Wootton et al., , 2006 . While the mechanism underlying the tissue-specific oncogenesis by JSRV and ENTV is still currently unknown, it is likely associated with their preferential LTR promoter activities in the lung and nasal tissues (Dakessian and Fan, 2008; Fan, 2006, 2007; Palmarini et al., 2000a) . Interestingly, despite their high sequence identities at the amino acid level in the SU subunit and that both viruses use the same cellular receptor, hyaluronidase2 (Hyal2), for entry, the infectivity and host ranges of JSRV and ENTV are remarkably different (Cousens et al., 1999; Dirks et al., 2002; Rai et al., 2000 Rai et al., , 2001 . JSRV Env-pseudotyped MLV vectors transduce a wide range of cell lines, including most human, monkey, dog, cow and rabbit cells (Rai et al., 2000) , whereas ENTV Env-based vectors only transduce certain sheep and human cell lines with a very low efficiency (Dirks et al., 2002) . Additionally, we recently reported that ENTV Env requires an unusually low pH (bpH 4.5) for fusion as compared to that of JSRV (bpH 6.0) (Côté et al., 2008a (Côté et al., , 2008b , and this likely contributes to the low infection rate of ENTV because of potential degradation of viral particles in the lysosome (Côté et al., 2008a) .
To understand the mechanism of fusion activation and cell entry by ENTV and JSRV, we previously generated several chimeras between these two Envs, and showed that the ENTV SU subunit is primarily responsible for its low fusion activity whereas the TM subunit dictates its unusual low pH threshold (Côté et al., 2008a) . Here, we aimed to further define the underlying mechanisms of the distinct fusogenicities between ENTV and JSRV Envs, and found that the relatively low fusion activity of ENTV SU is not because of poor receptor binding, but lies in its intrinsic insensitivity to receptor-mediated triggering. Our data support the notion that, while ENTV likely utilizes a similar two-step mechanism as that of JSRV for fusion and entry, there are differences in the SU subunits of these two Envs that critically regulate their distinct fusion activation.
Results
Identification of residues in the SU subunits of ENTV and JSRV Envs that determine their distinct entry efficiencies JSRV and ENTV share the same cellular receptor, Hyal2, for entry, yet the titer of ENTV Env pseudovirions in most mammalian cells, such as HTX that express an endogenous level of Hyal2, is extremely low as compared to that of JSRV (Table 1) (Dirks et al., 2002) . Remarkably, overexpression of Hyal2 in the target cells or the replacement of ENTV SU with that of JSRV dramatically rescues the ENTV titer (Table 1) (Côté et al., 2008a; Dirks et al., 2002; Van Hoeven and Miller, 2005) , suggesting that ENTV SU and its interaction with Hyal2 are responsible for its low entry efficiency. Sequence comparison reveals that ENTV SU is~94% identical to JSRV SU at the amino acid level (Cousens et al., 2004) , and the region between the signal peptide and residue 204 ( Fig. 1 , termed putative receptor binding domain (RBD)) has been previously identified to be the major determinant for differential infectivity of ENTV and JSRV Env pseudotypes (Dirks et al., 2002; Van Hoeven and Miller, 2005) . The putative RBD contains four most distinguishable changes between JSRV and ENTV, i.e., R/G-177 (R for ENTV and G for JSRV at position 177, same nomenclatures for the other mutants), T/S-180, N/H-191, and S/G-195 ( Fig. 1 ). Among these, T/S-180 is a putative N-linked glycosylation site (N-X-S/T) common to both ENTV and JSRV, while N191 constitutes an extra N-linked glycosylation site unique to ENTV.
We generated reciprocal Env mutants between ENTV and JSRV at these four positions in the RBD, and examined their effects on viral infection. The expression of these Envs and their incorporations into MLV vectors were comparable, except that ENTV Env and its mutants exhibited relatively higher levels of expression than those of JSRV as determined by flow cytometry and Western blot (data not shown; also see ref. (Côté et al., 2008a) ). MLV pseudotypes bearing individual Envs were used to transduce human HTX or HTX/LH2SN cells (the latter overexpress human Hyal2), and their titers were summarized in Table 1 . While reciprocal mutations between ENTV and JSRV Envs at position 177 and 180 did not significantly change the viral titers in either cell lines, substitution of ENTV S195 or N191 with the corresponding JSRV G195 or H191 increased the ENTV titer by~10 to 100-fold in HTX and HTX/LH2SN cells (Table 1) . A double mutant harboring both S195G and N191H did not appear to further increase the ENTV titer (Table 1) . Interestingly, the reciprocal JSRV G195S mutant, but not that of H191N, exhibited a~10-to100-fold decreased titer in both cell lines, and the double mutant, JSRV H191N/G195S, showed a further drop in the infection titer (Table 1) .
Taken together, these results indicated that residues at position 191 and 195 are critical for ENTV and JSRV entry, with those at position 195 likely playing a more important role. We cannot rule out the possibility that other residues in the SU subunit, particularly the two additional residues in the RBD, i.e., 174 and 196, may also contribute to the differential entry efficiency of JSRV and ENTV.
The SU subunits of ENTV and JSRV Envs are differentially glycosylated We next performed metabolic labeling assays and examined the expression, processing, and possible glycosylations of these JSRV and ENTV Env proteins and their SU mutants. As shown in Fig. 2 , all the JSRV and ENTV Env constructs were expressed and processed with similar efficiencies, as evidenced by comparable band intensities for the precursors (labeled as "FL") and processed TMs ( Fig. 2A) . Table 1 Titers of MoMLV pseudovirions bearing JSRV Env, ENTV Env or their SU mutants (AP + foci per ml).
Env
HTX HTX/LH2SN ENTV SU WT 14 ± 8 (2.8 ± 1.1) × 10 5 R177G 31 ± 4 (7.7 ± 0.1) × 10 4 T180A 37 ± 3.4 (1.8 ± 0.2) × 10 4 T180S 31 ± 3.0 (1.9 ± 0.8) × 10 5 N191H
(1.0 ± 0.2) × 10 3 (1.0 ± 0.2) × 10 5 S195G
(2.0 ± 0.3) × 10 3 (2.4 ± 1.7) × 10 6 N191H/S195G
(2.3 ± 0.4) × 10 3 (2.7 ± 0.6) × 10 6 JSRV SU WT (3.9 ± 0.1) × 10 4 (3.3 ± 1.0) × 10 6 G177R (7.1 ± 0.7) × 10 4 (6.6 ± 2.1) × 10 6 S180A
(2.2 ± 0.5) × 10 4 (2.4 ± 0.2) × 10 6 S180T
(2.3 ± 0.2) × 10 4 (1.4 ± 1.8) × 10 6 H191N
(1.7 ± 0.5) × 10 4 (5.3 ± 2.2) × 10 6 G195S
(2.4 ± 1.3) × 10 3 (5.6 ± 0.5) × 10 4 H191N/G195S
(1.5 ± 0.5) × 10 2 (7. Noticeably, reciprocal mutants at position 191 (i.e, ENTV N191H and JSRV H191N) and 180 (i.e, ENTV T180A and JSRV S180A), where their putative N-linked glyscosylation sites were disrupted or gained, exhibited altered electrophoretic mobilities distinct from their respective wildtypes ( Fig. 2A ). As would be expected, point mutations at the same position 180 that retain the potential N-linked glycosylation sites, i.e., ENTV T180S and JSRV S180T, displayed electrophoretic patterns similar to their wildtypes ( Fig. 2A ). Together, these results indicated that the position 180 is indeed a N-linked glycosylation site common to both ENTV and JSRV. Similar results were also obtained for shed SU harvested from the culture media, although ENTV Env and its mutants exhibited generally stronger signals as compared to those of JSRV and mutants ( Fig. 2C ). We then treated the Env-containing cell lysates with PNGase F, and observed that all the ENTV and JSRV Env constructs exhibited greatly reduced but similar size of FL, SU, and TM on the gel, with roughly the same molecular weights (Fig. 2B ). The decreased band intensity for the PNGase F-treated samples shown in Fig. 2B likely resulted from the deglycosylation that made the protein bands look sharper. Together, these metabolic labeling data support the notion that both ENTV and JSRV Envs are extensively glycosylated in the SU subunits (there is a total of 6 and 7 potential N-linked glycosylation sites in the JSRV and ENTV SUs, respectively), and the distinct gel mobilities observed between ENTV and JSRV SU are due to their differential N-linked glycosylations at position 191.
Two residues in the SU subunits of ENTV and JSRV Envs distinguish their fusogenicities
The viral infection assay we employed to obtain the titers shown in Table 1 was based on the JSRV and ENTV pseudotypes; therefore, their titer differences should reflect the effect of SU changes on virus entry including membrane fusion. We thus assessed the fusion activities of ENTV and JSRV SU mutants using the syncytia induction and cell-cell fusion assays we developed previously (Côté et al., 2008b) . While the wildtype ENTV Env induced small and fewer syncytia at pH 5.0 following a prolonged 5-min pulse or a pH 4.5 treatment for 1 min as we had shown previously, the N191H and S195G mutants produced relatively larger (2-fold) and more syncytia (~2-3 times) under the same conditions (pictures not shown). Quantitatively, the cell-cell fusion activities of these two mutants were significantly higher than that of ENTV wildtype (p b 0.05), although this was only evident at pH 4.0 ( Fig. 3 ), a Fig. 1 . Sequence alignment of JSRV and ENTV SU. JSRV-7 (GenBank accession number AF357971) and ENTV-1 (Y16627 and AF401741) are two representative strains of JSRV and ENTV. The alignment was performed using Clustal W (asterisk, invariant; colon, highly similar; dot, similar). The positions of signal peptide (SP), putative receptor-binding domain (RBD), and transmembrane (TM) subunit are according to (Dirks et al., 2002) . Four reciprocal mutation sites in the RBD between JSRV and ENTV are indicated. condition that is necessary to apparently detect the ENTV Env-mediated membrane fusion in the cell-based assay (Côté et al., 2008a) . Interestingly, the JSRV G195S mutant, but not that of H191N, exhibited a significantly reduced cell-cell fusion activity (p b 0.01) at all the acidic pH tested (Fig. 3) . Kinetics studies revealed that the fusion activation of JSRV G195S mutant was also much slower than that of JSRV wildtype and other mutants (data not shown). We noticed that, although both ENTV N191H and S195G mutants exhibited increased fusogenicity, they still required an extremely low pH (bpH 4.5) for fusion activation as that of ENTV wildtype ( Fig. 3 , data not shown), supporting our previous conclusion that the TM subunit, rather than that of SU, determines the unusually low pH threshold of ENTV Env for fusion (Côté et al., 2008a) . Overall, the cell fusion data demonstrate that residues at position 191 and 195 in the ENTV and JSRV SU critically modulate their fusogenicities.
ENTV SU binds to Hyal2 as efficiently as does the JSRV SU
The observed effects of reciprocal SU mutants on membrane fusion and infection of JSRV and ENTV could be simply explained by their differences in binding to the Hyal2 receptor. To explore this possibility, we created soluble SU-human IgG Fc fusion proteins for some of the key JSRV and ENTV SU mutants, and performed a series of in vitro binding assays. We first examined the size and glycosylation patterns of the purified fusion proteins using SDS-PAGE in combination with SYPRO staining and Western blot. The electrophoretic mobilities of these fusion proteins on the gel were generally consistent with those seen in cell lysates and culture media shown in Fig. 2 , with the reciprocal N191H and H191N mutants exhibiting altered mobilities (Fig. 4A ). PNGase F treatment rendered all the ENTV and JSRV SU fusion proteins to roughly the same size on the gel ( Fig. 4A) , again suggesting that ENTV SU has a unique N-linked glycan at the position 191 relative to the JSRV SU.
We next performed ELISA using purified SU fusion proteins and soluble Hyal2 (sHyal2) that we recently generated from Drosophila S2 cells (Côté et al., 2009) . We found that, quite unexpectedly, the binding activities of wildtype ENTV and JSRV SU to sHyal2 were very similar at all the different concentrations of SU fusion proteins or sHyal2 being tested (Fig. 4B , data not shown). Consistently, all the ENTV and JSRV SU mutants also exhibited comparable binding activities to sHyal2, with levels similar to their wildtypes (data not shown).
To rule out the possibility that the ELISA results may not reflect the SU-Hyal2 interactions in cultured cells, we performed in vitro SU binding assays using HTX and HTX/LH2SN cells expressing different levels of Hyal2. Again, we observed similar fluorescence intensities for the ENTV and JSRV wildtypes in both cell lines ( Fig. 4C) , with different amounts of fusion proteins being tested (data not shown). The ENTV and JSRV SU fusion protein mutants also exhibited comparable binding activities to Hyal2 in HTX and HTX/LH2SN cells, although slight decreases were noted for some of the ENTV mutants ( Fig. 4D) . We further carried out virion-cell binding experiments using Gag-YFP-expressing MLV pseudotypes bearing individual Envs, and obtained similar binding profiles for all the Env constructs in both HTX and HTX/LH2SN cells (data not shown). Taken together, our data suggest that ENTV and JSRV Envs have similar binding activities to Hyal2, at least in the cell lines we tested, and that the relatively low fusogenicity and infectivity of ENTV cannot be explained by receptor binding. These results are in line with a previous report by Van Hoeven and Miller, which showed similar binding efficiencies of ENTV and JSRV SU fusion proteins to several cell lines engineered to overexpress human Hyal2 (Van Hoeven and Miller, 2005) .
Unlike JSRV SU, shedding of ENTV SU is not enhanced by soluble Hyal2
Shedding or displacement of the receptor binding subunit of retroviral Env or SU upon receptor binding has been shown to be an important, though not necessary, indicator of retrovirus Env-mediated fusion and infection (Eckert and Kim, 2001; Thali et al., 1992; Wallin et al., 2005) . Recent data from our group also demonstrated that shedding of JSRV SU into culture media is enhanced by sHyal2, supporting the conclusion that Hyal2 plays a priming role in the pH-dependent, Env-mediated fusion (Côté et al., 2009) . Here, we wished to examine if shedding of ENTV SU could also be enhanced by sHyal2 and whether or not the SU mutations could have any effect on the SU shedding. We metabolically labeled the ENTV and JSRV Env-expressing 293T cells in the presence of varying amounts of sHyal2, and the shed SU proteins were immunoprecipitated from culture media and analyzed by autoradiography. Shedding of JSRV SU was enhanced by sHyal2 in a dose-dependent manner, similar to what we had shown previously (Côté et al., 2009) ; however, no enhanced SU shedding could be observed for ENTV Env, even with the highest amount of sHyal2 used (Fig. 5A) . Remarkably, we found that the JSRV G195S mutant reproducibly failed to show an enhanced SU shedding following the sHyal2 treatment, and this was in sharp contrast to the wildtype JSRV and other JSRV SU mutants (Fig. 5B ). We were unable to detect an enhanced SU shedding for any of the ENTV SU mutants, including the reciprocal S195G mutant (Fig. 5C ) and the N191H/S195G double mutant (data not shown).
Despite the lack of enhancement by sHyal2, we constantly observed higher basal levels of SU shedding for ENTV Env and its mutants relative to that of JSRV constructs (Figs. 2 and 5A and C) . To determine if the SU or TM subunit of Env is responsible for differential basal level of SU shedding between JSRV and ENTV, we performed metabolical labeling assay using two chimeric Envs in which the SU and TM subunits of JSRV and ENTV are reciprocally swapped (Côté et al., 2008a) . We observed that JE, which harbors the JSRV SU and ENTV TM, exhibited a higher basal level of SU shedding, similar to that of ENTV, and that the SU shedding was further enhanced by sHyal2 resembling that of JSRV Env (Fig. 5D ). In contrast, EJ which contains the ENTV SU but JSRV TM, failed to show any detectable SU shedding in the absence or presence of sHyal2 (Fig. 5D ). These results further support the notion that ENTV SU is indeed inherently less sensitive to sHyal2-mediated SU triggering for shedding compared to that of JSRV, and that the relatively higher basal levels of ENTV SU shedding is largely controlled by the TM subunit.
ENTV Env pseudovirions are not readily inactivated by soluble Hyal2, the effect of which can be overcome by amino acid substitutions in the SU It is generally believed that viral fusion proteins undergoing dramatic conformational refolding following fusion triggering are locked into a stable post-fusion conformation (White et al., 2008) . Therefore, virions that are prematurely subjected to these triggers are often, though not always, inactivated in the absence of the host target membrane (White et al., 2008) . We recently showed that the infectivity of JSRV Env pseudovirions is not inactivated by low pH but can be severely impaired by sHyal2, supporting the idea that Hyal2 is directly involved in the pH-dependent membrane fusion activation of JSRV Env (Côté et al., 2008b (Côté et al., , 2009 ). Here, we tested if sHyal2 could also inactivate the infectivity of ENTV Env pseudovirions and some of the ENTV and JSRV mutants. We incubated the ENTV and JSRV Env pseudovirions with different amounts of sHyal2 either before or after virus binding to the target HTX/LH2SN cells, and this would allow us to distinguish the effect of sHyal2 on virus binding at the surface of the target cells and the inactivation of Env. As shown previously (Côté et al., 2009) , sHyal2 potently inhibited the infection of JSRV pseudovirions in both the pre-binding ( Fig. 6A ) and post-binding ( Fig. 6B ) assays, with the half-maximal inhibition concentrations of~1 μg and 1.5 μg per ml, respectively. In contrast, the infectivity of ENTV pseudovirions, despite being inhibited, was not effectively inactivated by sHyal2 in the pre-binding assay (reflecting both receptor binding and fusion), especially at low concentrations of sHyal2 (with halfmaximal inhibition concentration of~7 μg/ml, Fig. 6A ). This was even more apparent in the post-binding assay, where marked differences between ENTV and JSRV were noted at all the various doses of sHyal2 being tested (Fig. 6B) . Altogether, these results demonstrate Fig. 3 . Cell-cell fusion activities of JSRV and ENTV SU mutants. Effector cells (293 T/GFP) transfected with plasmid DNA encoding various Envs were incubated with target cells (HTX/LH2SN) for 1 h, followed by treatment with indicated pH buffers for 1 min (JSRV) or 5 min (ENTV). Cells were then incubated in fresh growth media for 1 h at 37°C, trypsinized, and analyzed by flow cytometry. (A) Dot plots from one representative experiment are presented; the percentages of fused cells were indicated in the upper-right quadrant of the cytometry profiles. Note that all the JSRV constructs were treated with pH 5.0 for 1 min, and all the ENTV constructs were with pH 4.0 for 5 min. (B) Relative cell-cell fusion activities. The relative fusion activities of JSRV and ENTV SU mutants were obtained by comparing with their own wildtype JSRV at pH 5.0 (set as 100%, left) or ENTV at pH 4.0 (set as 100%, right). The paired student's t test was used for statistical analysis; * indicates p b 0.05, and ** indicates p b 0.01. that ENTV Env pseudovirions are not as sensitive as those of JSRV to the sHyal2-mediated inactivation, which is in line with the above observation that sHyal2 was unable to induce enhanced ENTV SU shedding as it did on the JSRV SU (Fig. 5A) .
We next performed similar post-binding assays for some of the JSRV and ENTV SU mutants, and these results are summarized in Figs. 6C and D. We observed that, although the infectivity of the JSRV H191N mutant was inhibited by 10 μg sHyal2 (~3-fold), it was less sensitive to treatment by lower concentrations of sHyal2, such as 0.5 and 1.5 μg (Fig. 6C) . Strikingly, we found that the infectivity of the JSRV G195S mutant was barely inhibited by sHyal2 at all the different amounts of sHyal2 being tested (for 1.5 μg sHayl2) (Fig. 6C) . In contrast, the infectivities of two ENTV SU mutants, N191H and S195G, were reproducibly inhibited in a dosedependent manner (pb 0.05 or 0.01, Fig. 6D ). Collectively, these results reinforce the notion that the amino acid residues at both 191 and 195 positions of ENTV and JSRV SUs are critical for sHyal2-mediated fusion activation, with residues at 195 playing the most critical role.
Discussion
A remarkable difference between JSRV and ENTV is the extremely poor transduction efficiency of ENTV Env-bearing pseudotypes as compared to that of JSRV (Dirks et al., 2002) . A simple hypothesis is that ENTV SU has a lower binding activity to Hyal2 than that of JSRV SU, and this would restrict its fusion activation and cell entry efficiency (Côté et al., 2008a; Dirks et al., 2002; Van Hoeven and Miller, 2005) . However, we find here that ENTV SU binds to Hyal2 as efficiently as does the JSRV SU, and that the low fusogenicity of ENTV Env is associated with its intrinsic insensitivity to Hyal2-mediated triggering. We provided evidence that two amino acid residues in the SU subunits of ENTV and JSRV Envs are critical for their distinct fusion activation and cell entry efficiency.
Hyal2 plays an essential role in the pH-dependent fusion activation of JSRV and ENTV Env proteins (Côté et al., 2008a (Côté et al., , 2008b (Côté et al., , 2009 . We propose that Hyal2 may initiate a conformational change of SU and thus causes SU disassociation from TM; subsequently the TM subunit undergoes dramatic conformational rearrangements upon low pH triggering, resulting in the formation of 6HB and thereby membrane fusion (Côté et al., 2009) . Consistent with this model, we showed here and previously that shedding of JSRV SU is enhanced by sHyal2 (Côté et al., 2009 ). However, here we have been repeatedly unable to detect an enhanced SU shedding for ENTV, even with the largest amounts of sHyal2 being tested (Figs. 5A, C and D) . We observed higher basal levels of SU shedding for ENTV Env (Figs. 2 and 5 ), which correlates with its higher level of Env expression relative to that of JSRV ( Fig. 5 ; also ref. (Côté et al., 2008a) ) and appeared to be dictated by the TM subunit (Fig. 5D ). While we cannot rule out the possibility that the association of ENTV SU and TM may be weaker than that of JSRV in the native, pre-fusion state, or/and that a coreceptor may be involved in the ENTV Env-mediated entry (including fusion trigger responsible for the basal level of SU shedding) as previously proposed by Dusty Miller and colleagues (Van Hoeven and Miller, 2005) , we favor the hypothesis that the local structure of ENTV SU is different from that of JSRV and this likely render the ENTV SU intrinsically less sensitive to Hyal2-mediated triggering for fusion activation. In addition to the SU shedding data, this hypothesis is further supported by the observation that sHyal2 does not efficiently inactivate the ENTV Env pseudovirions, the effect of which is otherwise rescued by amino acid substitutions in the ENTV SU with that of JSRV (Fig. 6) .
We identified residues in the position 191 and 195 of ENTV and JSRV SU to be critical for their differential membrane fusion activation by Hyal2. Both N191 and S195 are absolutely conserved among all the ENTV (also referred to as ENTV-1 in sheep) strains published to date, including the recently reported 10 ENTV isolates from North America (Walsh et al., 2010) . Interestingly, the only ENTV sequence that was cloned from a goat (referred to ENTV-2) (Ortin et al., 2003) and almost all the endogenous sheep retroviruses (known as enJSRV) reported (Arnaud et al., 2007; Palmarini et al., 2000b) harbor the H191 and G195 residues, which are typical of JSRV. While the fusion property of ENTV-2 has yet to be determined, MLV pseudotypes bearing the enJSRV Envs exhibit a host range similar to that of JSRV (our unpublished data), further supporting the notion that these two residues play a critical role in the distinct fusion activation and cell entry of sheep betaretroviruses. However, it is somewhat puzzling as to how ENTV (i.e., ENTV-1) with an intrinsically low fusogenicity spreads in sheep and causes nasal adenocarcinomas in vivo. Perhaps, the nasal epithelial cells of sheep express high levels of Hyal2 receptor, which may compensate for the low fusogenicity of ENTV and therefore facilitate the viral spreada situation analogous to the Hyal2 overexpression in the cultured cells (Table 1) . This hypothesis may also explain why ENTV infection in sheep is strictly Fig. 5. sHyal2 does not enhance the ENTV SU shedding as it does to the JSRV SU. 293T cells transfected with plasmid DNA encoding JSRV Env, ENTV Env or their SU mutants were metabolically labeled for 1 h and chased for 3 h. Indicated amounts of sHyal2 were then added to the media, and cells were incubated for 3 additional hours at 37°C. Immunoprecipitated Envs from cell lysates and media were resolved on SDS-PAGE and subjected to autoradiography. SU shedding was quantified using Quantity One software (Bio-Rad) and band densities were normalized to the shed SU of JSRV (A, B and D) or ENTV (C) in the absence of sHyal2 (which were set as 1.00). Representative images from three experiments are shown. None: untransfected control. * indicates nonspecific cellular proteins that were pulled down by anti-FLAG beads. EJ and JE are two chimeric Envs between JSRV and ENTV; EJ contains ENTV SU and JSRV TM, whereas JE contains JSRV SU and ENTV TM, see ref. (Côté et al., 2008a) for details. localized to the nasal tumor tissues and does not establish disseminated infections in lymph nodes and peripheral blood mononuclear cells, which are often observed for JSRV in sheep and ENTV-2 in goats (Ortin et al., 2003; Palmarini et al., 1996) .
The most critical residues that we identified to determine the distinct patterns of Hyal2-mediated fusion activation and cell entry between ENTV and JSRV are located at the position 195 of SU. We showed that replacement of ENTV S195 with JSRV G195 substantially increased the ENTV Env-mediated fusion activity at low pH (Fig. 3) , enhanced its pseudotype transduction (Table 1) , and also rendered the ENTV Env pseudovirions more sensitive to sHyal2-mediated inactivation ( Fig. 6 ). Opposite effects were also observed for the reciprocal G195S mutant of JSRV (Table 1, Figs. 3 and 6) . One possibility is that S195 may form a hydrogen bond with a surrounding amino acid residue, and this could make the ENTV SU less flexible and therefore less sensitive to Hyal2-mediated triggering as compared to that of JSRV. In this case, position 195 is likely located in the interaction interface between Hyal2 and SU and therefore modulates the conformational changes of SU upon receptor binding. Alternatively, position 195 may sit within the SU-TM interface and could be involved in relieving the restraints of SU on the TM upon Hyal2 triggering.
Since both possibilities relate to the position of residues 191 and 195 within the pre-fusion conformation of the JSRV and ENTV Env, we endeavored to model its pre-fusion structure. No pre-fusion structures are available for a retroviral SU but a pre-fusion structure was resolved for the Ebola virus glycoprotein GP (Lee et al., 2008) . Ebola GP2 has been shown to be a member of the cl02885: Ebola_ HIV-1-like_HR1-HR2 superfamily of viral glycoproteins that includes those of JSRV, HIV-1, the simian and feline immunodeficiency viruses, and many human endogenous retroviruses (Marchler-Bauer et al., 2011) . The receptor binding domain of Ebola GP1 (Dube et al., 2009 ) and the fusion peptide and heptad repeats of GP2 (for review see (Dutch et al., 2000) ) have been identified. We aligned the JSRV receptor binding domain with that of Ebola GP1 and the JSRV TM with that of Ebola GP2 and submitted the alignment to SwissModel molecular modeling program (Arnold et al., 2006; Guex and Peitsch, 1997 ). Fig. 7 shows a portion of the molecular surface of the JSRV Env model that includes the segment containing residues 191 and 195. Surprisingly, these two residues are predicted to fold adjacent to (H191) and just beneath (G195) the fusion peptide in TM, favoring the alternative possibility that the residues lie in the SU-TM interface in a position to influence the stability of the pre-fusion Env. The additional hydrogen bonds provided by S195 and N191 could stabilize Env against receptor triggering, thus requiring greater numbers of receptor to be present on host cells for infection. In this regard, it is very interesting to note that an HIV-1 gp120 H66N mutant has been recently found to locate between the receptor-binding and gp41-interactive surface of gp120 and stabilize the HIV-1 Env complex once the CD4bound state is established (Kassa et al., 2009) . Future work should aim to solve the 3-D structures of JSRV and ENTV SU in order to understand the conformational changes of ENTV and JSRV SUs upon Hyal2 binding, particularly the roles of key amino acid residues in modulating the fusion activation processes.
Materials and methods

Cell lines and reagents
293T, 293T/GFP (293T cells stably expressing GFP), HTX (a subclone of HT1080), 293/LH2SN (293 cells stably expressing human Hyal2), HTX/LH2SN (HTX cells stably expressing human Hyal2), and 293/GP-LAPSN (a packaging cell line stably expressing MoMLV Gag-Pol and MoMLV retroviral vector encoding alkaline phosphatase) have been described previously (Côté et al., 2008b; Miller and Chen, 1996; Rai et al., Fig. 6 . ENTV Env pseudovirions are not effectively inactivated by sHyal2, the effect of which can be otherwise rescued by amino acid substitutions in the SU by those of JSRV. (A) Prebinding assay. MLV pseudotypes bearing JSRV or ENTV Env were incubated with indicated amounts of sHyal2 for 30 min at 4°C prior to infection of HTX/LH2SN cells. (B-D) Postbinding assay. MLV pseudotypes bearing JSRV Env, ENTV Env, or SU mutants were bound to HTX/LH2SN cells at 4°C for 1 h; unbound virus was removed by washing, and cells were then incubated with indicated amounts of sHyal2. In both cases, the titers were determined by AP staining 72 h post-infection. Relative infection was calculated by setting the titers in the absence of soluble Hyal2 as 100%. Paired student t test was used for statistical analysis; * indicates p b 0.05; ** denotes p b 0.01. 2001). All cell lines were cultured in Dulbecco's Modified Eagle medium (DMEM) (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS) and maintained at 37°C in a 10% CO 2 -air atmosphere at 100% relative humidity. The fluorescent dye, 5-(and-6)-(((4-chloromethyl) benzoyl) amino) tetramethylrhodamine (CMTMR), and Lipofectamine 2000 were purchased from Invitrogen. The anti-FLAG monoclonal antibody beads (EZview™ Red), and the secondary antihuman IgG antibody coupled to fluorescein isothiocyanate (FITC) were purchased from Sigma (St. Louis, MO).
Constructs
The parental JSRV and ENTV Env-encoding vectors, with a FLAG tag at both the N-and C-termini, have been previously described (Côté et al., 2008a (Côté et al., , 2008b . Point mutations in the SU subunits of JSRV and ENTV Envs were introduced by overlapping PCR using the parental JSRV and ENTV Env-encoding plasmids as templates. The parental JSRV and ENTV SU fused with human IgG Fc portion have also been described previously (Liu et al., 2003a; Van Hoeven and Miller, 2005) ; the point mutations in the SU region were generated using the Quickchange Site-directed Mutagenesis kit (Stratagene, La Jolla, CA) with some modifications or overlapping PCR strategy (Liu et al., 2003b) . All mutants were confirmed by DNA sequencing.
Metabolic labeling
The metabolic labeling assay was performed as described previously (Côté et al., 2008b) . Briefly, 293T cells were transfected using the calcium phosphate method; 24 h post-transfection, cells were starved in cysteine/methionine-free media for 30 min at 37°C, and pulsed with 62.5 μCi 35 S-cysteine/methionine for 1 h at 37°C. The radiolabelled proteins were chased for 6 h, and Env proteins in supernatants and cell lysates were immunoprecipitated using anti-FLAG beads (Sigma). Immunoprecipated proteins were either left untreated, or subjected to treatment with 500 units PNGase F (New England BioLabs, Ipswich, MA) overnight, resolved on SDS-PAGE, and visualized using a Phosphor Imager. Where applicable, appropriate amounts of sHyal2 were added to the media following a 3-h chase period; cells were chased for an additional 3 h before Env proteins in the supernatants and cell lysates were immunoprecipitated and analyzed.
Cell-based fusion assays
The syncytium induction assay was performed as described previously (Côté et al., 2008a (Côté et al., , 2008b . Briefly, 293/LH2SN cells plated in 6well plates were transfected with 2 μg of plasmid DNA encoding Env and 0.5 μg of pCMV-GFP-encoding plasmid (kindly provided by François-Loïc Cosset, Lyon, France) using the calcium phosphate method. Twenty-four hours post-transfection, cells were treated with a pH 5.0 buffer (PBS-10 mM HEPES-10 mM MES) for either 1 or 5 min at 37°C. Cells were then incubated at 37°C in complete growth media, and pictures were taken 1 h after the treatment using a fluorescence microscope (Carl Zeiss, Goettingen, Germany).
For the cell-cell fusion assay, 293T/GFP cells were transfected using Lipofectamine 2000 (Invitrogen) with plasmid DNAs encoding individual Envs. Twenty-four hours post-transfection, cells were detached using PBS-0.5 mM EDTA, and co-cultured at a 2:1 ratio with CMTMR pre-labeled effector HTX/LH2SN cells for 1 h at 37°C. For JSRV Env-expressing cells, cells were treated for 1 min with pH 4.5, 5.0, 5.5 or 7.0, and allowed to recover in normal growth medium for 1 h. For ENTV Env-expressing cells, wells were pre-coated with poly-L-lysine (Sigma) (to prevent cell detachment due to the more acidic pH treatment) and cells were co-cultured for 1 h prior to a 5min treatment with pH 4.0, 4.5 or 7.0. In all cases, cells were trypsinized and analyzed by flow cytometry using a FACSCalibur (BD Bioscience, Mississauga, ON, Canada).
Protein purification
The production and purification of soluble Hyal2 (sHyal2) has been described previously (Côté et al., 2009; Vigdorovich et al., 2005) . The JSRV and ENTV SU fusion proteins as well as their mutants were produced by transfection of 293T cells using the calciumphosphate method. Twelve hours post-transfection, cells were fed with media containing 2% ultra-low IgG FBS (Invitrogen). The fusion proteins were purified using recombinant protein A beads (GE Health, Uppsala, Sweden) as described previously (Liu et al., 2003a) , with size and purity determined by SDS-PAGE and Sypro Ruby staining (Bio-Rad, Hercules, CA).
ELISA and SU binding assays sHyal2 (0.50 μg per well) was coated on ELISA plates (Costar, Lowell, MA) overnight at 4°C. Plates were blocked using 5% milk, 0.05% Tween-20 in PBS for 1 h at room temperature and washed three times with wash buffer (PBS, 0.05% Tween-20). Fusion proteins were incubated for 1 h at 37°C and unbound proteins were washed three times. Bound fusion proteins were detected using anti-human IgG coupled to HRP and 2, 2'-azino-bis (3-ethylbenzthiazoline-6-sulphonic acid (ABTS, Sigma). For SU fusion protein binding assays, HTX cells or HTX/LH2SN cells overexpressing Hyal2 were incubated for 3 h at 4°C with 10 μg of purified fusion proteins. Following 3 washes with PBS plus 2% FBS, cells were stained with FITC-coupled anti-human IgG, and analyzed by flow cytometry.
Pseudovirion production, binding, and infection
The packaging 293/GP-LAPSN cell line was transfected with plasmids encoding individual Envs to produce alkaline phosphatase (AP)-expressing pseudovirions. Supernatants were harvested 48 and 72 h post-transfection, and cell debris was removed by centrifugation Fig. 7 . Molecular modeling of the pre-fusion structure of JSRV Env suggests that residues 191 and 195 lie on the interface of SU and TM and modulate receptor triggering by influencing the stability of the pre-fusion structure. A portion of the molecular surface of the pre-fusion JSRV Env model rendered using 3-D Molecule (Vector NTI) is shown. Arrows point to the locations of residues 191 and 195 (shown in red). H191 is predicted to lie on the surface interacting with residues in the fusion peptide while G195 is not visible because it is predicted to lie below the surface beneath the fusion peptide. The remaining residues in the segment 188 to 199 are shown in green. The fusion peptide is shown in yellow. All other residues are shown in white.
at 3200 × g. Titer was measured by infection of HTX and HTX/LH2SN cells in the presence of 5 μg/ml Polybrene (Sigma), and AP-positive foci were counted 72 h post-infection as previously described (Côté et al., 2008a) . Pseudovirions containing MLV Gag-YFP were produced by co-transfection of 293/GP-LAPSN cells with Env-encoding plasmids together with an MLV Gag-YFP encoding plasmid (kind gift of Walther Mothes, Yale University, New Haven, CT) at a ratio of 2.5:1. Comparable transfection efficiency was verified by fluorescence microscopy. Virions were harvested at 48 and 72 h post-transfection, and were purified by ultracentrifugation on 20% sucrose cushion as described previously (Côté et al., 2008a) . Equal amounts of virions were used for binding to HTX and HTX/LH2SN cells for 3 h at 4°C in the presence of Polybrene. Unbound virions were washed three times with PBS plus 2% FBS, and remaining virions bound to cells were measured by flow cytometry.
For the virus inactivation assay, virions were pre-incubated with appropriate amounts of sHyal2 for 30 min at 4°C and then used to infect HTX/LH2SN cells in the presence of Polybrene. Alternatively, HTX/LH2SN cells were pre-bound with appropriate amounts of viral supernatant in the presence of Polybrene at 4°C for 1 h. Unbound virions were removed, and indicated amounts of sHyal2 were added to the media. AP + foci were counted 72 h post-infection. In each independent experiment, comparable multiplicity of infections (MOIs) were used for infection with all viral pseudotypes.
Molecular modeling
The RBD, fusion peptide and first heptad repeat of JSRV Env were aligned with the analogous domains of the Ebola Zaire GP and the alignment submitted for molecular modeling (SwissModel) using the prefusion structure of Ebola GP (3CSY) as a template. Only a portion of the molecular surface of the pre-fusion JSRV Env model rendered using 3-D Molecule (Vector NTI) is shown in this study.
